Skip to content
  • Home
  • Contact Us
  • About Us
  • Home
  • Contact Us
  • About Us
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 2, 2024

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More
Page1 Page2 Page3 … Page7
RECENT POSTS

Kylian Mbappe Criticizes Viral Dictator Meme for Lack of Awareness

September 11, 2026

IMF Discusses Senegal’s Debt Restructuring and Economic Reforms

September 11, 2026

Children Die in a School Fire in Bukavu

September 11, 2026

Angolan National Agency for Petroleum, Gas and Biofuels (ANPG) Secures New Deepwater Deals at Angola Oil and Gas 2026

September 11, 2026

BRICS to Launch Own Cross-Border Payment System, BRICS Pay

September 11, 2026

New Ebola Treatment Centre Opens in Kisangani to Enhance Response Efforts

September 11, 2026

DR Congo’s Ebola Outbreak Shows Divergent Transmission Trends: WHO

September 9, 2026

Mahama Urges Ghana Football Association to Revitalize Youth Leagues

September 9, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.